Kortek Corporation (KOSDAQ:052330)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	118,326	101,390	89,845	129,959	142,526	128,388
Market Cap Growth	8.64%	12.85%	-30.87%	-8.82%	11.01%	-32.81%
Enterprise Value	53,414	23,449	49,417	165,394	129,037	36,514
Last Close Price	9350.00	7850.00	6348.83	8557.61	9132.05	8226.17
PE Ratio	4.83	3.72	11.34	4.60	-	-
PS Ratio	0.37	0.33	0.28	0.30	0.67	0.69
PB Ratio	0.33	0.28	0.27	0.38	0.49	0.43
P/TBV Ratio	0.35	0.30	0.29	0.41	0.50	0.44
P/FCF Ratio	25.24	17.24	1.03	-	-	-
P/OCF Ratio	16.95	11.82	0.97	-	-	12.84
EV/Sales Ratio	0.17	0.08	0.15	0.39	0.61	0.20
EV/EBITDA Ratio	1.50	0.82	5.11	5.08	-	10.37
EV/EBIT Ratio	1.74	1.00	11.42	6.08	-	-
EV/FCF Ratio	11.40	3.99	0.56	-	-	-
Debt / Equity Ratio	0.13	0.11	0.22	0.21	0.08	0.01
Debt / EBITDA Ratio	1.27	1.40	7.56	2.17	-	0.64
Debt / FCF Ratio	9.67	6.79	0.84	-	-	-
Asset Turnover	0.72	0.68	0.70	1.04	0.63	0.55
Inventory Turnover	2.47	2.39	2.28	2.89	2.46	2.86
Quick Ratio	2.62	2.84	1.87	1.49	1.41	6.98
Current Ratio	3.94	4.11	2.72	2.65	3.30	9.89
Return on Equity (ROE)	8.37%	7.62%	2.26%	9.21%	-4.56%	-2.76%
Return on Assets (ROA)	4.30%	3.25%	0.58%	4.13%	-2.72%	-0.18%
Return on Capital (ROIC)	4.82%	3.62%	0.66%	4.70%	-2.99%	-0.19%
Return on Capital Employed (ROCE)	8.40%	6.40%	1.30%	7.90%	-	-
Earnings Yield	25.33%	26.91%	8.82%	21.72%	-9.43%	-6.63%
FCF Yield	3.96%	5.80%	97.28%	-15.96%	-59.95%	-10.18%
Dividend Yield	2.67%	3.19%	3.15%	2.92%	-	3.04%
Payout Ratio	9.15%	10.06%	45.05%	-	-	-
Buyback Yield / Dilution	10.91%	6.49%	-22.68%	-4.67%	1.23%	2.88%
Total Shareholder Return	13.39%	9.67%	-19.53%	-1.74%	1.23%	5.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.